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Introduction: Facial diplegia, a rare variant of Guillain-Barré syndrome (GBS), is a challenging 
diagnosis to make in the emergency department due to its resemblance to neurologic Lyme disease.
Case report: We present a case of a 27-year-old previously healthy man who presented with 
bilateral facial paralysis.
Discussion: Despite the variance in presentation, the recommended standard of practice for 
diagnostics (cerebrospinal fluid albumin-cytological dissociation) and disposition (admission for 
observation, intravenous immunoglobulin, and serial negative inspiratory force) of facial diplegia are 
the same as for other presentations of GBS.
Conclusion: When presented with bilateral facial palsy emergency providers should consider 
autoimmune, infectious, idiopathic, metabolic, neoplastic, neurologic, and traumatic etiologies 
in addition to the much more common neurologic Lyme disease. [Clin Pract Cases Emerg Med. 
2020;4(2):150–153.]
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INTRODUCTION
Facial diplegia is a rare variant of Guillain-Barré 
syndrome (GBS) where patients present with bilateral facial 
paralysis and paresthesia. Patients usually present 1-28 days 
after onset of symptoms, occasionally with extremity 
paresthesia but often in isolation.2 This variant occurs in less 
than 1% of all GBS patients.1-2 The pathophysiology of the 
disease is due to the acute inflammatory demyelinating 
polyneuropathy subtype much more often than the acute motor 
axonal neuropathy subtype of GBS.2 Due to its resemblance to 
the far more prevalent neurologic Lyme disease, it can be a 
potential pitfall diagnosis for emergency providers. 
CASE REPORT
A 27-year-old male military recruit without significant 
previous medical history was transported to the emergency 
department (ED) by ambulance with a chief complaint of 
bilateral facial paralysis. A resident of Puerto Rico, the 
Brooke Army Medical Center, Department of Emergency Medicine, Fort Sam Houston, Texas
patient had recently traveled to San Antonio, Texas, for 
military exercises and received multiple vaccines five days 
prior to onset of symptoms. He began experiencing mild 
paresthesia in his hands and feet four days prior to ED 
presentation. He reported progressive neurologic signs and 
symptoms including being unable to close his eyes or mouth, 
which made sleeping and eating difficult, as well as right-
sided facial numbness. He went to the military medical clinic 
two days prior to ED presentation where he was diagnosed 
with a complex migraine and discharged to the barracks on 
quarters (strict bed rest) with ibuprofen and ondansetron and 
instructions to return for follow-up the next day to evaluate 
for resolution of symptoms.
During the subsequent ED visit his vital signs included a 
heart rate of 113 beats per minute, blood pressure 117/76 
millimeters of mercury, respiration 16 breaths per minute, 
and temperature 98.5 degrees Fahrenheit. His blood glucose 
was 116 milligrams per deciliter (mg/dL) (90-120 mg/dL). 
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What do we already know about this clinical 
entity? 
The treatment and disposition for all variants of 
Guillain-Barré syndrome (GBS) is the same. 
What makes this presentation of disease 
reportable? 
Facial diplegia is a rare variant of GBS that 
mimics a fairly common disease process in 
Lyme disease
What is the major learning point? 
This case demonstrates the differential 
diagnosis and diagnostic pitfalls associated 
with facial diplegia.
How might this improve emergency 
medicine practice? 
Clinicians should consider a thorough 
differential diagnosis for facial diplegia.
Physical exam revealed symmetric bilateral facial paralysis, 
causing difficulty in closing his eyelids and mouth, which 
resulted in injected conjunctiva with moderate tearing, and 
cheilitis (Image). He endorsed decreased soft-touch sensation 
in a radial distribution in his upper extremities and the 
distribution of his fifth lumbar nerve in his lower extremities. 
Bilateral Achilles reflexes were absent. Strength and reflexes 
were otherwise preserved in his lower extremities. He was 
administered one liter of Ringer’s lactate, and the 
tachycardia improved. 
Computed tomography of his head showed no masses or 
evidence of bleeding. Neurology was consulted and per their 
recommendation we obtained magnetic resonance imaging of 
his brain, which demonstrated no lesions, masses, or 
evidence of edema. A lumbar puncture was performed; it 
revealed albumin-cytological dissociation of cerebrospinal 
fluid (CSF), which is an increased protein with normal cell 
counts. Polymerase chain reaction did not detect any 
common bacterial or viral meningitis organisms. His 
complete blood count, comprehensive metabolic panel, and 
erythrocyte sedimentation rate were all within normal limits. 
The patient was given 10 milligrams dexamethasone 
intravenously in the ED, and blood cultures were obtained 
prior to admission. 
With a presumptive diagnosis of GBS the patient was 
admitted to the hospital for serial negative inspiratory flow 
measurements and intravenous immune globulin (IVIG), while 
awaiting further diagnostic testing by neurology. Serum and CSF 
studies detected none of the following organisms: Borrelia 
burgdorferi, Zika virus, West Nile virus, varicella-zoster virus, 
Treponema pallidum, human immunodeficiency virus, or 
Mycobacterium tuberculosis. Based upon the exam findings and 
diagnostic testing, the diagnosis of facial diplegia (GBS variant) 
was confirmed with the etiology most likely post-vaccinal. The 
patient received four days of IVIG and was discharged from the 
hospital. He returned to training with 4/5 strength and decreased 
light touch in his bilateral face and complete resolution of the 
paresthesia in his extremities. He was started on long-term daily 
corticosteroids by the neurologist with continued 4/5 strength and 
light touch in his bilateral face noted on his one month follow-up.
 
DISCUSSION
Facial diplegia is a rare disorder, accounting for less than 
2% of all patients with facial paralysis.1 The differential of 
facial diplegia includes Lyme disease, meningitis, and trauma. 
While Lyme disease is the most common etiology, GBS 
accounts for about 5% of cases (Table).1-3 Although facial nerve 
paralysis is involved in 27-50% of GBS cases (50% of those 
Image. Patient with facial diplegia attempting to both wrinkle 
forehead and smile during neurologic exam.
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patients having bilateral involvement), facial diplegia is a rare 
presentation, occurring in 0.25-0.8% of all GBS patients. 
Causes are thought to be the same as in other variants of GBS.2,4
Common features of GBS include the following: subjective 
peripheral paresthesia (88%); a preceding illness one to two 
weeks prior to symptoms (75%); and CSF albumin-cytological 
dissociation (88%).4 The diagnostic criteria include core features 
of facial weakness, absence of ophthalmoplegia or truncal/
cervical ataxia, and monophasic disease course with 12 hours to 
28 days between onset and nadir. Supportive features include 
antecedent infectious symptoms, presence of distal paresthesia 
prior to facial diplegia, electrophysiological evidence of 
neuropathy, and CSF albumin-cytological dissociation.5
The prognosis for the facial diplegia subtype of GBS is 
generally favorable, as diaphragmatic paralysis has never been 
documented.2 Corticosteroids, although classically given, have 
not been shown to be effective in GBS.2 Although there have 
been no GBS-variant specific trials of treatment that show IVIG 
efficacy, the recommended standard of practice is still admission 
for observation, IVIG, and serial negative inspiratory force.2
CONCLUSION 
Facial diplegia is a rare variant of GBS that presents a 
very challenging diagnosis to make in the ED due to its wide 
differential diagnosis. When presented with bilateral facial 
palsy emergency providers should consider autoimmune, 
infectious, idiopathic, metabolic, neoplastic, neurologic, and 
traumatic etiologies in addition to the much more common 
neurologic Lyme disease. Facial diplegia is a clinical 
diagnosis that is bolstered by the presence of albumin-
cytological dissociation in the cerebral spinal fluid.2 Treatment 
is the same as for other variants of GBS: observation; serial 
negative inspiratory force; and IVIG if the patient’s condition 
begins to deteriorate. 
Documented patient informed consent has been obtained and 
filed for publication of this case report.
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Category Diagnosis
Autoimmune Guillain-Barré syndrome
Sarcoidosis
Myasthenia gravis
Amyloidosis
Infectious
Lyme disease
Herpes simplex virus
Varicella-zoster virus
Human immunodeficiency virus 
Syphilis  
Human T-cell leukemia virus-1
Poliomyelitis
Influenza
Cytomegalovirus
Botulism
Epstein-Barr virus
Idiopathic
Idiopathic intracranial hypertension
Bell’s palsy
Metabolic
Diabetes
Neoplastic
Leukemia
Porphyria
Meningioma 
Neurological
Multiple sclerosis
Trauma
Skull fracture
Parotid surgery
Mastoid surgery
Table. Differential diagnosis of acute onset bilateral facial paralysis.
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